| Outcome Measures: |
Primary: Proportion of subjects who achieve composite endpoint of HbA1c <7.0% and ≥10% weight loss, Week 32 | Secondary: Proportion of subjects who achieve composite endpoint of HbA1c <7.0% and ≥15% weight loss, Week 32|Proportion of subjects who achieve composite endpoint of HbA1c <7.0% and ≥5% weight loss, Week 32|Proportion of subjects who achieve composite endpoint of HbA1c<6.5% and ≥5%, ≥10% or ≥15% weight loss, Week 32|Change from Baseline in HbA1c, Week 32|Change from Baseline in Fasting Plasma Glucose, Week 32|Proportion of subjects who achieve composite endpoint of HbA1c <7.0%，≤6.5% or <5.7%, Week 32|Percent Change from Baseline in Body Weight, Week 32|Change from Baseline in Waist Circumference, Week 32|Proportion of subjects who achieve ≥5%, ≥10% or ≥15% weight loss, Week 32|Change from Baseline in Blood Pressure(Systolic and Diastolic), Week 32|Percent Change from Baseline in Triglycerides, Total Cholesterol, LDL-c, HDL-c, non-HDL-c, Week 32
|
